This compound is primarily utilized in the pharmaceutical industry as an intermediate in the synthesis of various active pharmaceutical ingredients (APIs). Its structure, featuring a difluorophenyl group, makes it valuable in the development of drugs targeting neurological disorders, including antidepressants and antipsychotics. The presence of the methylamine moiety enhances its reactivity, facilitating its incorporation into more complex molecules. Additionally, it is employed in research settings to study the effects of fluorinated compounds on biological systems, aiding in the discovery of new therapeutic agents. Its applications extend to the development of fluorinated analogs of existing drugs, which can improve pharmacokinetic properties such as bioavailability and metabolic stability.